Results

Biohaven Pharmaceutical Holding Company Ltd.

05/23/2022 | Press release | Distributed by Public on 05/23/2022 05:39

US FDA Accepts for Review Biohaven's New Drug Application (NDA) Filing of Intranasal Zavegepant for the…